N. Manceñido

发表

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.

J. Gisbert, R. García-Castellanos, M. Chaparro, 2012, Journal of Crohn's & colitis.

Current concepts on microscopic colitis: evidence‐based statements and recommendations of the Spanish Microscopic Colitis Group

J. Gisbert, M. Piqueras, A. Lucendo, 2016, Alimentary pharmacology & therapeutics.

Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy

J. Gisbert, X. Calvet, M. Piqueras, 2015, Journal of clinical gastroenterology.

Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement

J. Mate, J. Gisbert, F. Bermejo, 2009, Inflammatory bowel diseases.

Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients

C. Taxonera, M. Iborra, E. Cerrillo, 2020, Scientific Reports.

Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study

C. Andreu, A. Gómez, I. Thuissard, 2021, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

M. Chaparro, C. Taxonera, A. López-Sanromán, 2015, Journal of Crohn's & colitis.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

J. Gisbert, X. Calvet, M. Piqueras, 2022, Frontiers in Medicine.

Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry

J. Gisbert, X. Calvet, M. Piqueras, 2021, Journal of Crohn's & colitis.

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

C. Taxonera, A. Algaba, M. Iborra, 2019, Current medical research and opinion.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.

F. Casellas, J. Gisbert, X. Calvet, 2018, Gastroenterologia y hepatologia.

Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients

F. Casellas, J. Mate, J. Gisbert, 2011, Alimentary pharmacology & therapeutics.

Prevalence and antimicrobial-resistance of S. pneumoniae and S. pyogenes in healthy children in the region of Madrid.

R. Herruzo, N. Manceñido, A. López, 2002, International journal of pediatric otorhinolaryngology.

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.

M. Sans, X. Calvet, L. Bujanda, 2010, Journal of Crohn's & colitis.

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.

M. J. Cabello, J. Gisbert, D. Busquets, 2022, Digestive and Liver Disease.

Polyphenols and Ulcerative Colitis: An Exploratory Study of the Effects of Red Wine Consumption on Gut and Oral Microbiome in Active‐Phase Patients

B. Bartolomé, M. Moreno-Arribas, D. Taladrid, 2022, Molecular nutrition & food research.

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

J. Gisbert, M. Piqueras, A. Lucendo, 2022, Journal of clinical medicine.

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

M. Piqueras, L. Bujanda, D. Busquets, 2022, Journal of clinical medicine.

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

J. Gisbert, M. Piqueras, A. Lucendo, 2020, Journal of Crohn's & colitis.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

J. Gisbert, D. Busquets, A. Gutiérrez, 2017, Inflammatory bowel diseases.

Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' Perspectives.

J. Muñiz, J. Pérez-Calle, P. Nos, 2022, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Diffuse cavernous hemangioma of the rectum: an atypical cause of rectal bleeding.

R. Pajares Villarroya, N. Manceñido, D. Hervías, 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Efectiveness And Safety Of Ustekinumab In Elderly Patients With Crohn's Disease: Real World Evidence From The Eneida Registry.

J. Gisbert, L. Bujanda, M. Chaparro, 2022, Journal of Crohn's & colitis.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2021, American Journal of Gastroenterology.

Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases

J. Pascual, A. Lucendo, N. Manceñido, 2007, European journal of gastroenterology & hepatology.

A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer

J. Feliu, J. Maurel, J. Sánchez, 2011, Clinical Cancer Research.

Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement

J. Mate, J. Gisbert, F. Bermejo, 2009, Inflammatory Bowel Diseases.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2022, The American journal of gastroenterology.

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.